WANT A PROFILE LIKE THIS?
Create my FREE Plan Or learn about other options
Dezső Módos
PeerJ Editor & Reviewer
1,680 Points

Contributions by role

Reviewer 175
Editor 1,505

Contributions by subject area

Bioinformatics
Gastroenterology and Hepatology
Oncology
Computational Biology
Statistics
Data Science
Genomics
Pediatrics
Evidence Based Medicine
Translational Medicine
Women's Health
Molecular Biology
Dermatology
Cell Biology
Medical Genetics
Otorhinolaryngology
Biochemistry
Immunology
Neurology
Respiratory Medicine
Allergy and Clinical Immunology
Gynecology and Obstetrics
Internal Medicine
Pharmacology
Urology
Data Mining and Machine Learning
Genetics

Dezső Módos

PeerJ Editor & Reviewer

Summary

I am a medical doctor and a systems biologist. During my scientific carrier, I have tried to understand diseases and find novel approaches to treat them with drugs, whether it is cancer or UC. I finished the Semmelweis University Doctor of Medicine course on 2012 and then started my PhD in network biology. I was involved in developing multiple biological network databases transcription factor-target layers such as SignaLink, AutophagyRegulatory Network or the NRF2Ome. My main project was to understand signalling networks in cancer and how the different paralogues of a protein can act in the signalling network.

Since then I have been a Postdoctoral Research Associate at Cambridge University, where my main focus was how can we use networks to predict mechanisms of action of compound combinations. I used various chemical informatics techniques besides network biology such as chemical fingerprints, machine learning and gene expression-based toxicity prediction.

Currently, I am working at the Earlham Institute and Quadram Institut in Norwich researching inflammatory bowel disease and using network biology to decipher the pathogenesis of complex disorders.

I have recently moved to Imperial College, London to go through the therapeutic celling in IBD using systems biology.

Bioinformatics Computational Biology Data Science Statistics Theoretical & Computational Chemistry

Editorial Board Member

PeerJ - the Journal of Life & Environmental Sciences

Past or current institution affiliations

Imperial College School of Medicine
University of Cambridge

Work details

Research Scientist

Quadram Institute Bioscience
December 2019
Systems Biology of Gut-Microbe Interactions
I am working at the Quadram Institute as a postdoctoral research scientist researching the interactions between host and microbiota networks.

Research Assocaite

Imperial College School of Medicine
April 2023
Metabolism Digestion and Reproduction

Research Associate

University of Cambridge
January 2016 - September 2019
Department of Chemistry
I was a research associate and Solyom Scholarship Fellow as visiting scholar at the Bender Group.

Websites

  • Google Scholar
  • ResearcherID
  • LinkedIn

PeerJ Contributions

  • Edited 7
  • Reviewed 4

Academic Editor on

December 14, 2023
Phar-LSTM: a pharmacological representation-based LSTM network for drug–drug interaction extraction
Mingqing Huang, Zhenchao Jiang, Shun Guo
https://doi.org/10.7717/peerj.16606 PubMed 38107590
January 25, 2023
Construction of a ceRNA network of regulated ferroptosis in doxorubicin-induced myocardial injury
Hongwei Ye, Yuping Li, Lu Li, Yuhui Huang, Jiahui Wang, Qin Gao
https://doi.org/10.7717/peerj.14767 PubMed 36718444
November 25, 2022
Investigating isoform switching in RHBDF2 and its role in neoplastic growth in breast cancer
Mehar Masood, Madahiah Bint E Masood, Noor Us Subah, Maria Shabbir, Rehan Zafar Paracha, Mehak Rafiq
https://doi.org/10.7717/peerj.14124 PubMed 36452073
December 22, 2021
Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
Zihao Yan, Siwen Chu, Chen Zhu, Yunhe Han, Qingyu Liang, Shuai Shen, Wen Cheng, Anhua Wu
https://doi.org/10.7717/peerj.12547 PubMed 35036121
August 24, 2021
The modulatory properties of Astragalus membranaceus treatment on endometrial cancer: an integrated pharmacological method
Qianqian Zhang, Xianghua Huang
https://doi.org/10.7717/peerj.11995 PubMed 34513331
January 14, 2021
Tumor microenvironment related novel signature predict lung adenocarcinoma survival
Juan Chen, Rui Zhou
https://doi.org/10.7717/peerj.10628 PubMed 33520448
August 18, 2020
Significance of hub genes and immune cell infiltration identified by bioinformatics analysis in pelvic organ prolapse
Ying Zhao, Zhijun Xia, Te Lin, Yitong Yin
https://doi.org/10.7717/peerj.9773 PubMed 32874785

Signed reviews submitted for articles published in PeerJ Note that some articles may not have the review itself made public unless authors have made them open as well.

July 14, 2021
Identification of consistent post-translational regulatory triplets related to oncogenic and tumour suppressive modulators in childhood acute lymphoblastic leukemia
YongKiat Wee, Yining Liu, Min Zhao
https://doi.org/10.7717/peerj.11803 PubMed 34316412
April 2, 2021
Utilizing network pharmacology and molecular docking to explore the underlying mechanism of Guizhi Fuling Wan in treating endometriosis
Haoxian Wang, Gang Zhou, Mingyan Zhuang, Wei Wang, Xianyun Fu
https://doi.org/10.7717/peerj.11087 PubMed 33859874
July 30, 2019
Identification of significant gene and pathways involved in HBV-related hepatocellular carcinoma by bioinformatics analysis
Shucai Xie, Xili Jiang, Jianquan Zhang, Shaowei Xie, Yongyong Hua, Rui Wang, Yijun Yang
https://doi.org/10.7717/peerj.7408 PubMed 31392101
June 25, 2019
Cancer driver genes: a guilty by resemblance doctrine
Emilie Ramsahai, Vrijesh Tripathi, Melford John
https://doi.org/10.7717/peerj.6979 PubMed 31275738